RiethPharma
0824.514.648 · rovalta.com · 22/09/2026
RiethPharma
Overview
What does RiethPharma do?
RiethPharma is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Mortsel.
2640 Mortsel · FlandreSee on map
Joint committees (2)
- 313
- 31300
Trend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2012 | 2011 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||
| Gross margin | 16,6 k € | -50.1% | 33,3 k € | +1.2% | 32,9 k € | +61.9% | 20,3 k € | -74.1% | 78,4 k € | -40.4% | 131,5 k € | -44.2% | 235,7 k € |
| EBITDA | 16,4 k € | +1398% | -1,3 k € | +62.1% | -3,3 k € | +70.7% | -11,4 k € | -149% | 23,4 k € | -64.3% | 65,5 k € | -46.7% | 122,9 k € |
| Operating result | 15,4 k € | +827% | -2,1 k € | +44.0% | -3,8 k € | +68.0% | -11,8 k € | -154% | 21,9 k € | -54.1% | 47,8 k € | -49.6% | 94,8 k € |
| Net result | 9,9 k € | +265% | -6 k € | +2.4% | -6,2 k € | +52.4% | -13 k € | -151% | 25,3 k € | -10.2% | 28,2 k € | -42.8% | 49,3 k € |
| Balance sheet | |||||||||||||
| Equity | 68,5 k € | +17.0% | 58,5 k € | -9.3% | 64,6 k € | -8.7% | 70,7 k € | -15.5% | 83,7 k € | -41.9% | 143,9 k € | +7.2% | 134,3 k € |
| Total assets | 138,9 k € | +22.0% | 113,9 k € | -17.2% | 137,6 k € | +5.2% | 130,9 k € | -25.5% | 175,7 k € | -51.0% | 358,4 k € | +0.4% | 356,8 k € |
| Cash | 2,6 k € | -47.1% | 4,9 k € | +65.5% | 2,9 k € | +0.2% | 2,9 k € | -94.4% | 52,1 k € | -64.4% | 146,6 k € | +9.6% | 133,7 k € |
| Debts | 69 k € | +28.5% | 53,7 k € | -26.4% | 73 k € | +21.5% | 60,1 k € | -34.7% | 92 k € | -55.8% | 208,3 k € | -1.4% | 211,2 k € |
| Other | |||||||||||||
| Workforce | 0,0 ETP | -100% | 0,4 ETP | 0.0% | 0,4 ETP | – | – | 1,0 ETP | 0.0% | 1,0 ETP | |||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 9 ended
Other companies at this address
| Company | CBE no. |
|---|---|
KW-BEHEER● Active | 0771.451.886 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/08/2026 | 15/07/2025 | 23/07/2024 | 29/08/2023 | 29/08/2022 | 26/07/2021 |
| General meeting | 07/05/2026 | 02/05/2025 | 02/05/2024 | 04/05/2023 | 05/05/2022 | 28/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
15 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 07/05/2026 | 04/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 02/05/2025 | 15/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 02/05/2024 | 23/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 04/05/2023 | 29/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 05/05/2022 | 29/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 28/06/2021 | 26/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 22/06/2020 | 22/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 24/06/2019 | 31/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 25/06/2018 | 31/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 26/06/2017 | 20/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/06/2016 | 01/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 22/06/2015 | 24/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 23/06/2014 | 21/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 24/06/2013 | 31/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 25/06/2012 | 29/08/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 9 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20259,9 k €↑
- 2024Annual accounts 2024-6 k €↑
- 2023Annual accounts 2023-6,2 k €↑
- 2022Annual accounts 2022-13 k €↓
- 2021Annual accounts 202125,3 k €↓
- 2021Name changeRiethPharma
- 2012Annual accounts 201228,2 k €↓
- 2011Annual accounts 201149,3 k €
- 2011Name changeApotheek Tytgat-Wauters
- 24/03/2010IncorporationPrivate limited company